134 related articles for article (PubMed ID: 25378085)
1. Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination.
Grün N; Ährlund-Richter A; Franzén J; Mirzaie L; Marions L; Ramqvist T; Dalianis T
Infect Dis (Lond); 2015 Jan; 47(1):57-61. PubMed ID: 25378085
[TBL] [Abstract][Full Text] [Related]
2. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
3. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
[TBL] [Abstract][Full Text] [Related]
4. Six-month natural history of oral versus cervical human papillomavirus infection.
D'Souza G; Fakhry C; Sugar EA; Seaberg EC; Weber K; Minkoff HL; Anastos K; Palefsky JM; Gillison ML
Int J Cancer; 2007 Jul; 121(1):143-50. PubMed ID: 17354235
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.
Du J; Ährlund-Richter A; Näsman A; Dalianis T
Arch Gynecol Obstet; 2021 Feb; 303(2):329-335. PubMed ID: 33247317
[TBL] [Abstract][Full Text] [Related]
6. Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden.
Ramqvist T; Du J; Lundén M; Ahrlund-Richter S; Ferreira J; Marions L; Sparén P; Andersson S; Dalianis T
Scand J Infect Dis; 2011 Feb; 43(2):115-21. PubMed ID: 20964488
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of oral human papillomavirus infection among youth, Sweden.
Du J; Nordfors C; Ahrlund-Richter A; Sobkowiak M; Romanitan M; Näsman A; Andersson S; Ramqvist T; Dalianis T
Emerg Infect Dis; 2012 Sep; 18(9):1468-71. PubMed ID: 22932445
[TBL] [Abstract][Full Text] [Related]
8. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
Mollers M; Scherpenisse M; van der Klis FR; King AJ; van Rossum TG; van Logchem EM; Feltkamp MC; Meijer CJ; Snijders PJ; Boot HJ; de Melker HE
Cancer Epidemiol; 2012 Dec; 36(6):519-24. PubMed ID: 22906483
[TBL] [Abstract][Full Text] [Related]
10. Oral and cervical HPV infection in HIV-positive and HIV-negative women attending a sexual health clinic in São Paulo, Brazil.
Lima MD; Braz-Silva PH; Pereira SM; Riera C; Coelho AC; Gallottini M
Int J Gynaecol Obstet; 2014 Jul; 126(1):33-6. PubMed ID: 24792407
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR; Jaisamrarn U; Limson GA; Garland SM; Szarewski A; Romanowski B; Aoki F; Schwarz TF; Poppe WA; De Carvalho NS; Harper DM; Bosch FX; Raillard A; Descamps D; Struyf F; Lehtinen M; Dubin G;
Gynecol Oncol; 2012 Dec; 127(3):440-50. PubMed ID: 22940493
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cervical and oral human papillomavirus infections among US women.
Steinau M; Hariri S; Gillison ML; Broutian TR; Dunne EF; Tong ZY; Markowitz LE; Unger ER
J Infect Dis; 2014 Jun; 209(11):1739-43. PubMed ID: 24319284
[TBL] [Abstract][Full Text] [Related]
14. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Secord EA; Kapogiannis BG; Thornton S; Gillison ML
Sex Transm Dis; 2015 May; 42(5):246-52. PubMed ID: 25868136
[TBL] [Abstract][Full Text] [Related]
15. Oral human papillomavirus infection in women with cervical HPV infection: new data from an Italian cohort and a metanalysis of the literature.
Termine N; Giovannelli L; Matranga D; Caleca MP; Bellavia C; Perino A; Campisi G
Oral Oncol; 2011 Apr; 47(4):244-50. PubMed ID: 21429788
[TBL] [Abstract][Full Text] [Related]
16. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
Chaturvedi AK; Graubard BI; Broutian T; Pickard RKL; Tong ZY; Xiao W; Kahle L; Gillison ML
J Clin Oncol; 2018 Jan; 36(3):262-267. PubMed ID: 29182497
[TBL] [Abstract][Full Text] [Related]
17. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study.
Roteli-Martins CM; de Carvalho NS; Naud P; Teixeira J; Borba P; Derchain S; Tyring S; Gall S; Diaz A; Blatter M; Shier RM; Romanowski B; Quint WG; Issam J; Galindo C; Schuind A; Dubin G
Int J Gynecol Pathol; 2011 Mar; 30(2):173-84. PubMed ID: 21293281
[TBL] [Abstract][Full Text] [Related]
19. Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012.
Brouwer AF; Eisenberg MC; Carey TE; Meza R
BMC Infect Dis; 2015 Dec; 15():575. PubMed ID: 26689203
[TBL] [Abstract][Full Text] [Related]
20. National prevalence of oral HPV infection and related risk factors in the U.S. adult population.
Sanders AE; Slade GD; Patton LL
Oral Dis; 2012 Jul; 18(5):430-41. PubMed ID: 22251072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
